Parametrica Management’s bluebird bio BLUE Stock Holding History

Parametrica Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,505	Closed	-$374K	–	81
2022 Q2	$374K	Buy	+4,505	New	+$349K	0.41%	63
2022 Q1	–	Sell	-2,007	Closed	-$401K	–	234
2021 Q4	$401K	Sell	2,007 -843	-30%	-$199K	0.4%	37
2021 Q3	$706K	Sell	2,850 -501	-15%	-$143K	0.53%	40
2021 Q2	$1.39M	Buy	3,351 +440	+15%	+$174K	1.02%	32
2021 Q1	$1.08M	Buy	+2,911	New	+$1.43M	0.52%	45
2017 Q3	–	Sell	-481	Closed	-$655K	–	355
2017 Q2	$655K	Buy	+481	New	+$580K	0.61%	14
2015 Q4	–	Sell	-315	Closed	-$349K	–	67
2015 Q3	$349K	Buy	+315	New	+$574K	2.2%	10

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Parametrica Management's BLUE Position: Q3 2022 in Review

Parametrica Management sold out of bluebird bio (BLUE) in Q3 2022, closing a stake of 4,505 shares — an estimated $374K sold.

Parametrica Management first reported a position in BLUE in Q3 2015 and held it in 7 quarters. The position peaked at $1.39M in Q2 2021. 162 funds tracked by Wall St. Rank hold BLUE as of Q3 2022.

Parametrica Management reported no remaining bluebird bio position as of Q3 2022 after selling out during the quarter.
Parametrica Management sold 4,505 bluebird bio shares in Q3 2022, an estimated $374K.
Parametrica Management first reported a position in bluebird bio in Q3 2015 and held it in 7 quarters.
Parametrica Management's bluebird bio position peaked at $1.39M in Q2 2021.
162 funds tracked by Wall St. Rank held bluebird bio as of Q3 2022.

Based on Parametrica Management's 13F filing for Q3 2022, filed 3 Nov 2022.